Outcomes Following Relapse of Non-Hodgkin Lymphoma (NHL) or Chronic Lymphocytic Leukemia (CLL) After Nonmyeloablative Conditioning and Allogeneic Hematopoietic Cell Transplantation (HCT) From HLA-Matched Related or Unrelated Donors

Mohamed L. Sorror; Barry Storer; Brenda M. Sandmaier; Georg N. Franke; Ginna G. Laport; Thomas Chauncey; Edward Agura; Michael T. Maris; James Wade; Michael A. Pulsipher; Richard T Maziarz; Firoozeh Sahebi; Peter McSweeney; Benedetto Bruno; Lars indelov; V; Andrew M. Yeager; Andrew Rezvani; Dietger W Niederwieser; Karl G. Blume; Rainer F. Storb; and David G. Maloney